Publication: Broader Implications of Defining Standards for the Pluripotency of iPSCs
Loading...
Date
2009
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier BV
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Daley, George Q., M. William Lensch, Rudolf Jaenisch, Alex Meissner, Kathrin Plath, and Shinya Yamanaka. 2009. “Broader Implications of Defining Standards for the Pluripotency of iPSCs.” Cell Stem Cell 4 (3) (March): 200–201. doi:10.1016/j.stem.2009.02.009.
Abstract
We read with great interest the excellent review by Maherali and Hochedlinger (2008) that recommends standards for characterization of pluripotent stem cell lines, especially the many new lines being generated using factor-based reprogramming techniques (induced pluripotent stem cells, or iPSCs). Of note was the suggestion that iPSCs should be assessed for “functional differentiation through the highest-stringency test acceptable.” For murine iPSCs, this means germline transmission following blastocyst chimerism, and for human iPSCs this means assessment of teratoma pathology.
Description
Other Available Sources
Research Data
Keywords
Terms of Use
Metadata Only